Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway

被引:0
|
作者
Marta Szybowska
Ozgur Mete
Evan Weber
Josh Silver
Raymond H. Kim
机构
[1] University Health Network,Fred A. Litwin Family Center in Genetic Medicine
[2] University Health Network,Department of Laboratory Medicine and Pathobiology
[3] University of Toronto,Medical Genetics
[4] McGill University Health Centre,Department of Molecular Genetics
[5] University of Toronto,Division of Medical Oncology, Department of Medicine
[6] University of Toronto,Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Fred. A. Litwin Centre in Genetic Medicine
[7] University Health Network,undefined
[8] University of Toronto,undefined
来源
Endocrine Pathology | 2019年 / 30卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Neuroendocrine neoplasms (NENs) have been primarily associated with germline pathogenic variants in genes involved in chromatin remodeling (MEN1), cell cycle control (CDKN1B), PI3K/mTOR signaling (TSC1/2, PTEN) as well as pseudohypoxia (VHL, SDHx). Recent work has implicated various genes involved in DNA repair pathways in the pathophysiology of a subset of pancreatic neuroendocrine neoplasms, including BRCA2, via the homologous recombination pathway (HRD). To date, germline variants in other HRD pathway genes have not been described to contribute to NEN. PALB2, RAD51C, and BARD1 are additional tumor suppressor genes which also mediate repair of double stranded DNA breaks through the HRD pathway and are implicated in hereditary breast (PALB2; BARD1) and ovarian (RAD51C) cancer. Here we report three cases of NEN associated with germline pathogenic variants in PALB2 (pancreatic NEN), RAD51C (thymic NEN), and BARD1 (pancreaticoduodenal NEN) respectively, further linking the DNA repair pathway to NENs.
引用
收藏
页码:237 / 245
页数:8
相关论文
共 50 条
  • [1] Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway
    Szybowska, Marta
    Mete, Ozgur
    Weber, Evan
    Silver, Josh
    Kim, Raymond H.
    ENDOCRINE PATHOLOGY, 2019, 30 (03) : 237 - 245
  • [2] Germline pathogenic variants in patients with early-onset neuroendocrine neoplasms
    Riechelmann, Rachel Pimenta
    Donadio, Mauro Daniel Spina
    de Jesus, Victor Hugo Fonseca
    de Carvalho, Nathalia de Angelis
    Santiago, Karina Miranda
    Barros, Milton J.
    Lopes, Laura
    dos Santos, Gabriel Oliveira
    Formiga, Maria Nirvana
    Carraro, Dirce Maria
    Torrezan, Giovana Tardin
    ENDOCRINE-RELATED CANCER, 2023, 30 (06)
  • [3] Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
    Sorbye, H.
    Venizelos, A.
    Perren, A.
    Couvelard, A.
    Hjortland, G. O.
    Sundlov, A.
    Svensson, J.
    Garresori, H.
    Vestermark, L. W.
    Tabaksblat, E.
    Elvebakken, H.
    Knappskog, S.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 35 - 35
  • [4] Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
    Venizelos, Andreas
    Sorbye, Halfdan
    Elvebakken, Hege
    Perren, Aurel
    Lothe, Inger Marie B.
    Couvelard, Anne
    Hjortland, Geir Olav
    Sundlov, Anna
    Svensson, Johanna
    Garresori, Harrish
    Kersten, Christian
    Hofsli, Eva
    Detlefsen, Soenke
    Vestermark, Lene W.
    Ladekarl, Morten
    Tabaksblat, Elizaveta Mitkina
    Knappskog, Stian
    ENDOCRINE-RELATED CANCER, 2023, 30 (10)
  • [5] Prevalence and outcomes of germline pathogenic variants of homologous recombination repair genes in ovarian cancer
    Miwa, Maiko
    Kitagawa, Masakazu
    Asami, Yuka
    Kobayashi-Kato, Mayumi
    Watanabe, Takafumi
    Ogasawara, Aiko
    Hiranuma, Kengo
    Kato, Hisamori
    Saito, Motonobu
    Miyagi, Yohei
    Kato, Tomoyasu
    Yoshida, Hiroshi
    Momozawa, Yukihide
    Kohno, Takashi
    Shiraishi, Kouya
    Hasegawa, Kosei
    CANCER SCIENCE, 2024, 115 (12) : 3952 - 3962
  • [6] High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
    Birgitte Bertelsen
    Ida Viller Tuxen
    Christina Westmose Yde
    Migle Gabrielaite
    Mathias Husted Torp
    Savvas Kinalis
    Olga Oestrup
    Kristoffer Rohrberg
    Iben Spangaard
    Eric Santoni-Rugiu
    Karin Wadt
    Morten Mau-Sorensen
    Ulrik Lassen
    Finn Cilius Nielsen
    npj Genomic Medicine, 4
  • [7] High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
    Bertelsen, Birgitte
    Tuxen, Ida Viller
    Yde, Christina Westmose
    Gabrielaite, Migle
    Torp, Mathias Husted
    Kinalis, Savvas
    Oestrup, Olga
    Rohrberg, Kristoffer
    Spangaard, Iben
    Santoni-Rugiu, Eric
    Wadt, Karin
    Mau-Sorensen, Morten
    Lassen, Ulrik
    Nielsen, Finn Cilius
    NPJ GENOMIC MEDICINE, 2019, 4 (1)
  • [8] Germline whole-exome sequencing of patients with neuroendocrine neoplasms reveals pathogenic or likely pathogenic variants in a large subset of patients
    Sukrithan, V
    Boateng, I
    Jain, P.
    Liyanarachchi, S.
    Buss, J.
    Parwani, A.
    Shah, M.
    Konda, B.
    Brock, P.
    Eisfeld, A. K.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 36 - 36
  • [9] Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With Homologous Recombination Deficiency Pathogenic Germline Variants
    Terrero, Gretel
    Datta, Jashodeep
    Dennison, Jessica
    Sussman, Daniel A.
    Lohse, Ines
    Merchant, Nipun B.
    Hosein, Peter J.
    JAMA ONCOLOGY, 2022, 8 (06) : 938 - 940
  • [10] Germline Pathogenic Variants in Homologous Recombination and DNA Repair Genes in an Asian Cohort of Young-Onset Colorectal Cancer
    Toh, Ming Ren
    Chiang, Jian Bang
    Chong, Siao Ting
    Chan, Sock Hoai
    Ishak, Nur Diana Binte
    Courtney, Eliza
    Lee, Wei Hao
    Bin, Syed Muhammad Fahmy
    Al, Syed Abdillah
    Allen, John Carson, Jr.
    Lim, Kiat Hon
    Davila, Sonia
    Tan, Patrick
    Lim, Weng Khong
    Tan, Iain Bee Huat
    Ngeow, Joanne
    JNCI CANCER SPECTRUM, 2018, 2 (04)